Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine versus mepivacaine for anesthesia in lower impacted third molar surgery
IRCT20230716058806N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Sep 2023
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Impacted lower third molar comparing Lidocaine 2% with epinephrine side with Mepivacaine 3% side (2 arms). Primary endpoints: Pain during surgery and Pain after surgery. Started Sep 2023; status: completed.
02
Drugs
lidocainemepivacaineepinephrine
03
Conditions
Impacted lower third molar
Beyond the preview
Go deeper on IRCT20230716058806N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230716058806N1.